Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study

S Gantner , S Cuzin (1) , D Allavena , D Cabie , D Pugliese , D Valantin , D Bani-Sadr , V. Joly , D. Ferry , S Poizot-Martin , G Garraffo , D Peytavin , S. Fafi-Kremer , D. Rey , Dat'Aids Study Group (delpierre C. Collaborator)

1 LEASP - Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps

Domaines: Sciences du Vivant [q-bio]

S Gantner, S Cuzin, D Allavena, D Cabie, D Pugliese, et al.. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study. HIV Medicine, 2017, ⟨10.1111/hiv.12506⟩. ⟨hal-01906302⟩